Lipid Sciences Incorporated

(NASDAQ:LIPD)

	Jun 30, 2008	Mar 31, 2008	Dec 31, 2007	Sep 30, 2007
Operating revenue
Total Revenue	—	250	4	106
Operating Revenue	—	250	4	106
Adjustments To Revenue	—	—	—	—
Cost Of Sales	-32	-31	-38	-39
Cost Of Sales With Depreciation	—	—	—	—
Gross Operating Profit	32	281	42	145
Operating Expenses
Research And Development Expenses	1,256	1,638	2,795	2,596
Selling General And Administrative Expenses	746	897	1,512	986
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-1,970	-2,254	-4,265	-3,437
Operating Income	-2,002	-2,285	-3,701	-3,476
Depreciation	32	31	38	39
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-2,002	-2,285	-4,303	-3,476
Non Operating Expenses
Interest Expense	—	—	—	—
Pre Tax Income	-1,985	-2,239	-4,213	-3,339
Income Taxes	—	—	—	—
Minority Interest	—	—	—	—
Income Before Income Taxes	-1,985	—	-4,213	-3,339
Net Income From Continuing Operations	-1,985	-2,239	-4,213	-3,339
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	-1,985	-2,239	-4,213	-3,339
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-1,985	-2,239	-4,213	-3,339
Normalized Income	-1,985	-2,239	-4,213	-3,339
NetIncome Available For Common	-1,985	-2,239	-4,213	-3,339
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—

	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Operating revenue
Total Revenue	306	59	9	32
Operating Revenue	306	59	9	32
Adjustments To Revenue	—	—	—	—
Cost Of Sales	-167	-205	-219	-321
Cost Of Sales With Depreciation	—	—	—	—
Gross Operating Profit	473	264	228	353
Operating Expenses
Research And Development Expenses	9,267	7,559	7,170	8,603
Selling General And Administrative Expenses	4,396	4,254	3,508	3,437
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-13,190	-11,549	-10,450	-11,687
Operating Income	-12,755	-11,754	-10,669	-12,008
Depreciation	167	205	219	321
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-13,357	-11,754	-10,669	-12,008
Non Operating Expenses
Interest Expense	—	—	—	—
Pre Tax Income	-12,755	-11,177	-10,214	-11,644
Income Taxes	—	—	—	-2
Minority Interest	—	—	—	—
Income Before Income Taxes	-12,755	-11,177	-10,214	-11,644
Net Income From Continuing Operations	-12,755	-11,177	-10,214	-11,642
Net Income From Discontinued Operations	—	—	—	1,066
Net Income From Total Operations	-12,755	-11,177	-10,214	-10,576
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-12,755	-11,177	-10,214	-10,576
Normalized Income	-12,755	-11,177	-10,214	-11,642
NetIncome Available For Common	-12,755	-11,177	-10,214	-11,642
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—